Table 1. Comparison of the cancer incidences in the urban and rural registries of Nepal (2018).
| Sites | Rukum (AAR) | Kathmandu (AAR) | Rate ratio | 95% CI | |
|---|---|---|---|---|---|
| All sites of cancer: Male | 59.1 | 95.3 | 1.6 | 1.26–2.06 | Significant |
| All sites of cancer: Female | 51.4 | 98.1 | 1.9 | 1.52–2.40 | Significant |
| Stomach cancer: Male | 7.3 | 8.5 | 1.2 | 0.50–2.71 | Not Significant (NS) |
| Stomach cancer: Female | 2.6 | 4.2 | 1.6 | 0.52–4.98 | NS |
| Gallbladder cancer: Male | 2.9 | 5.5 | 1.9 | 0.66–5.44 | NS |
| Gallbladder cancer: Female | 2.4 | 7.4 | 3.1 | 1.35–7.06 | Significant |
| Lung cancer: Male | 13.2 | 18.1 | 1.4 | 0.79–2.39 | NS |
| Lung cancer: Female | 5.2 | 10.4 | 2 | 0.95–4.19 | NS |
| Breast cancer | 2.7 | 21.5 | 8 | 4.79–13.25 | Significant |
| Ovary cancer | 3.2 | 5.5 | 1.7 | 0.69–4.30 | NS |
| Cervix cancer | 13.2 | 8.7 | 0.7 | 0.33–1.32 | NS |
| Uterus cancer | 3.9 | 0.5 | 0.1 | 0.01–1.89 | NS |
| Prostate cancer | 3 | 3 | 1 | – | Same No difference |
| Thyroid cancer: Male | 4.2 | 1 | 0.2 | 0.03–2.10 | NS |
| Bladder cancer: Male | 1.3 | 5.7 | 4.4 | 1.60–12.01 | Significant |
Analysis based on Boyle and Parkin [14]